← All trials
NCT04743622
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 30, 2019
- Primary completion
- Jun 23, 2020
- Completion date
- Sep 13, 2020
- First posted
- Feb 8, 2021
- Last posted
- Feb 8, 2021
- Enrollment
- 57
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Cha Medical UniversityLead sponsor
- Cha Medical UniversityOverall official - principal investigator
- Samil Pharmaceutical Co., Ltd.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.